Base editing reached human trials, but the FDA's April 2026 NGS safety draft guidance reveals how far the regulatory...

24/7 ICU staffing emerges as critical factor in ARDS trial enrollment, with site selection now prioritizing round-the-clock research availability.

Evident launches Pramana POD scanner for small pathology labs, processing 25 slides per hour with built-in quality assessment to...

Payers report inconsistent ESR1 testing practices for advanced breast cancer, creating delays in targeted SERD treatment despite clinical evidence...

AHN Cancer Center launches RANDY'S Trial to test FDA-approved drugs for treating peritoneal fibrosis in abdominal cancer patients.

FDA Approves RYZUMVI for presbyopia treatment in adults. Viatris seeks commercial partner to bring the phentolamine eye drop to...

OptiTROP-Lung05's HR of 0.35 over pembrolizumab monotherapy looks decisive, until you ask whether that comparator still reflects standard of...

CluePoints earns third Scrip Awards shortlisting in eight years for its risk-based quality management software serving clinical research.

RBQM's $13.8M value driven 84% by Phase III timeline gains, with clinical phase durations shrinking up to 19% in...

Oncolytics Biotech completes GOBLET pancreatic cancer cohort enrollment, advancing pelareorep combination therapy evaluation in metastatic disease.